Biocon’s Denosumab Biosimilars Approved by EU Commission
July 3, 2025
Biocon Biologics Ltd , a fully integrated global biosimilars company and subsidiary of Biocon Ltd., announced that the European Commission (EC) has granted marketing authorisation in the